For cell-cycle synchronization, mESC (J1) cells124 (link) were treated with 1.25 mM Thymidine for 14 h and then 50 ng/mL Nocodazole for 7 h. G1 and S phase cells were collected at 1.5 h and 7 h, respectively, after Nocodazole release. mESCs were treated with DRB (100 μM) and ActD (1 μg/mL) for 3 h to inhibit transcription. For heterochromatin fractionation, sucrose gradient centrifugation of mESC nuclear extracts was performed as previously reported with modifications.125 (link),126 (link) For embryonic microinjection, ASO (5 μM) and AMO (1 mM) was injected into PN3 zygotes on a Leica DMI3000B microscope equipped with a Leica micromanipulator.
Free full text: Click here